BID-induced structural changes in BAK promote apoptosis

Nature Structural and Molecular Biology

Volumn 20, Issue 5, 2013, Pages 589-597

  Moldoveanu, Tudor ^a   Grace, Christy R ^a   Llambi, Fabien ^a   Nourse, Amanda ^a   Fitzgerald, Patrick ^a   Gehring, Kalle ^b   Kriwacki, Richard W ^a,c   Green, Douglas R ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BH3 PROTEIN; CALPAIN; PROTEIN BAD; PROTEIN BAK; PROTEIN BCL 2; PROTEIN BID; PROTEIN NOXA; RECOMBINANT PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; GENE MUTATION; MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION; MITOCHONDRION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN STRUCTURE;

EID: 85027931439     PISSN: 15459993     EISSN: 15459985     Source Type: Journal    
DOI: 10.1038/nsmb.2563     Document Type: Article

References (54)

1. Green, D.R. Apoptotic pathways: ten minutes to dead. Cell 121, 671-674 (2005).
2. Jiang, X. & Wang, X. Cytochrome C-mediated apoptosis. Annu. Rev. Biochem. 73, 87-106 (2004).
3. Tait, S.W. & Green, D.R. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat. Rev. Mol. Cell Biol. 11, 621-632 (2010).
4. Kuwana, T. et al. Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 111, 331-342 (2002).
5. Lindsten, T. et al. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol. Cell 6, 1389-1399 (2000).
6. Wei, M.C. et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292, 727-730 (2001).
7. Dewson, G. et al. To trigger apoptosis, Bak exposes its BH3 domain and homodimerizes via BH3:groove interactions. Mol. Cell 30, 369-380 (2008).
8. Dewson, G. et al. Bax dimerizes via a symmetric BH3:groove interface during apoptosis. Cell Death Differ. 19, 661-670 (2012).
9. Chipuk, J.E., Moldoveanu, T., Llambi, F., Parsons, M.J. & Green, D.R. The BCL-2 family reunion. Mol. Cell 37, 299-310 (2010).
10. Llambi, F. et al. A unified model of mammalian BCL-2 protein family interactions at the mitochondria. Mol. Cell 44, 517-531 (2011).
11. Chipuk, J.E. & Green, D.R. How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol. 18, 157-164 (2008).
12. Walensky, L.D. & Gavathiotis, E. BAX unleashed: the biochemical transformation of an inactive cytosolic monomer into a toxic mitochondrial pore. Trends Biochem. Sci. 36, 642-652 (2011).
13. Westphal, D., Dewson, G., Czabotar, P.E. & Kluck, R.M. Molecular biology of Bax and Bak activation and action. Biochim. Biophys. Acta 1813, 521-531 (2011).
14. Certo, M. et al. Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. Cancer Cell 9, 351-365 (2006).
15. Bird, G.H., Bernal, F., Pitter, K. & Walensky, L.D. Synthesis and biophysical characterization of stabilized ?-helices of BCL-2 domains. Methods Enzymol. 446, 369-386 (2008).
16. Gavathiotis, E., Reyna, D.E., Davis, M.L., Bird, G.H. & Walensky, L.D. BH3-triggered structural reorganization drives the activation of proapoptotic BAX. Mol. Cell 40, 481-492 (2010).
17. Gavathiotis, E. et al. BAX activation is initiated at a novel interaction site. Nature 455, 1076-1081 (2008).
18. Moldoveanu, T. et al. The X-ray structure of a BAK homodimer reveals an inhibitory zinc binding site. Mol. Cell 24, 677-688 (2006).
19. Kim, Y.W., Grossmann, T.N. & Verdine, G.L. Synthesis of all-hydrocarbon stapled ?-helical peptides by ring-closing olefin metathesis. Nat. Protoc. 6, 761-771 (2011).
20. Walensky, L.D. et al. Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix. Science 305, 1466-1470 (2004).
21. Gräslund, S. et al. The use of systematic N-and C-terminal deletions to promote production and structural studies of recombinant proteins. Protein Expr. Purif. 58, 210-221 (2008).
22. Wang, H. et al. Novel dimerization mode of the human Bcl-2 family protein Bak, a mitochondrial apoptosis regulator. J. Struct. Biol. 166, 32-37 (2009).
23. Gross, A. et al. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J. Biol. Chem. 274, 1156-1163 (1999).
24. Ku, B., Liang, C., Jung, J.U. & Oh, B.H. Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX. Cell Res. 21, 627-641 (2011).
25. Letai, A.G. Diagnosing and exploiting cancer's addiction to blocks in apoptosis. Nat. Rev. Cancer 8, 121-132 (2008).
26. Wei, M.C. et al. tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev. 14, 2060-2071 (2000).
27. Oltersdorf, T. et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435, 677-681 (2005).
28. Dai, H. et al. Transient binding of an activator BH3 domain to the Bak BH3-binding groove initiates Bak oligomerization. J. Cell Biol. 194, 39-48 (2011).
29. Strasser, A., Jost, P.J. & Nagata, S. The many roles of FAS receptor signaling in the immune system. Immunity 30, 180-192 (2009).
30. Kim, H. et al. Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis. Mol. Cell 36, 487-499 (2009).
31. Ren, D. et al. BID, BIM, and PUMA are essential for activation of the BAX-and BAK-dependent cell death program. Science 330, 1390-1393 (2010).
32. Du, H. et al. BH3 domains other than Bim and Bid can directly activate Bax/Bak. J. Biol. Chem. 286, 491-501 (2011).
33. Czabotar, P.E. et al. Bax crystal structures reveal how BH3 domains activate bax and nucleate its oligomerization to induce apoptosis. Cell 152, 519-531 (2013).
34. Leshchiner, E.S., Braun, C.R., Bird, G.H. & Walensky, L.D. Direct activation of full-length proapoptotic BAK. Proc. Natl. Acad. Sci. USA 110, E986-E995 (2013).
35. Ferrer, P.E., Frederick, P., Gulbis, J.M., Dewson, G. & Kluck, R.M. Translocation of a Bak C-terminus mutant from cytosol to mitochondria to mediate cytochrome C release: implications for Bak and Bax apoptotic function. PLoS ONE 7, e31510 (2012).
36. Oh, K.J. et al. Conformational changes in BAK, a pore-forming proapoptotic Bcl-2 family member, upon membrane insertion and direct evidence for the existence of BH3-BH3 contact interface in BAK homo-oligomers. J. Biol. Chem. 285, 28924-28937 (2010).
37. Dewson, G. et al. Bak activation for apoptosis involves oligomerization of dimers via their ?6 helices. Mol. Cell 36, 696-703 (2009).
38. Lovell, J.F. et al. Membrane binding by tBid initiates an ordered series of events culminating in membrane permeabilization by Bax. Cell 135, 1074-1084 (2008).
39. Edlich, F. et al. Bcl-xL retrotranslocates Bax from the mitochondria into the cytosol. Cell 145, 104-116 (2011).
40. Montessuit, S. et al. Membrane remodeling induced by the dynamin-related protein Drp1 stimulates Bax oligomerization. Cell 142, 889-901 (2010).
41. Liu, X. et al. Generation of mammalian cells stably expressing multiple genes at predetermined levels. Anal. Biochem. 280, 20-28 (2000).
42. Denisov, A.Y. et al. Structural model of the BCL-w-BID peptide complex and its interactions with phospholipid micelles. Biochemistry 45, 2250-2256 (2006).
43. Moldoveanu, T., Gehring, K. & Green, D.R. Concerted multi-pronged attack by calpastatin to occlude the catalytic cleft of heterodimeric calpains. Nature 456, 404-408 (2008).
44. Moldoveanu, T. et al. A Ca2+ switch aligns the active site of calpain. Cell 108, 649-660 (2002).
45. Verdine, G.L. & Hilinski, G.J. Stapled peptides for intracellular drug targets. Methods Enzymol. 503, 3-33 (2012).
46. Hill, J.M. NMR screening for rapid protein characterization in structural proteomics. Methods Mol. Biol. 426, 437-446 (2008).
47. Sattler, M., Schleucher, J. & Griesinger, C. Heteronuclear multidimensional NMR experiments for the structure determination of proteins in solution employing pulsed field gradients. Prog. Nucl. Magn. Reson. Spectrosc. 34, 93-158 (1999).
48. Keller, R. The computer aided resonance assignment tutorial. (CANTINA Verlag, Goldau, Switzerland, 2004).
49. Guerry, P. & Herrmann, T. Comprehensive automation for NMR structure determination of proteins. Methods Mol. Biol. 831, 429-451 (2012).
50. Güntert, P., Mumenthaler, C. & Wuthrich, K. Torsion angle dynamics for NMR structure calculation with the new program DYANA. J. Mol. Biol. 273, 283-298 (1997).
51. Laue, T.M., Shah, B.D., Ridgeway, T.M. & Pelletier, S.L. Computer-aided interpretation of analytical sedimentation data for proteins. in Analytical Ultracentrifugation in Biochemistry and Polymer Science (eds. Harding, S.E., Rowe, A.J. & Horton, J.C.) 90-125 (The Royal Society of Chemistry, 1992).
52. Brown, P.H., Balbo, A. & Schuck, P. Characterizing protein-protein interactions by sedimentation velocity analytical ultracentrifugation. Curr. Protoc. Immunol. 81, 18.15 (2008).
53. Schuck, P. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophys. J. 78, 1606-1619 (2000).
54. Balbo, A., Brown, P.H., Braswell, E.H. & Schuck, P. Measuring protein-protein interactions by equilibrium sedimentation. Curr. Protoc. Immunol. 81, 18.8 (2007).